Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s):  FENC

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.


TSX:FRX - Post by User

Comment by commissionson Mar 24, 2004 12:22pm
240 Views
Post# 7258512

RE: Great.

RE: Great.If you bought this 3 years ago you DID NOT make any profit.I bought my first shares on the IPO at $1.50 which will have a 3 year anniversery in May of this year, the stock went straight down from that point to.30 for a series of unfortunate circumstances of which none were the companies fault.I have averaged down numerous times to put myself in a great position going forward. Unlike alot of other bullboards which like to fashion them selves with a alot of bullsh$$ this board has been an intelligent vehicle to convey and sort through what is happening to share price with regards to what is happenning internally with the company.You are more than entitled to profit from what you learn here but please don't come in from nowhere with a story about profit when it is not true and was impossible.If you own the stock now you will be able to tell a great profit story over the next year and a half if you hold your stock. Commissions
Bullboard Posts